{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:13:26Z","timestamp":1779214406797,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["708041"],"award-info":[{"award-number":["708041"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["800924"],"award-info":[{"award-number":["800924"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["28100"],"award-info":[{"award-number":["28100"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007076","name":"Fondazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21198"],"award-info":[{"award-number":["21198"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.<\/jats:p>","DOI":"10.1038\/s41419-026-08555-x","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:26:13Z","timestamp":1775661973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The deubiquitinase activity of CYLD is required for B cell differentiation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-8119","authenticated-orcid":false,"given":"Athanasios","family":"Pseftogas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bordini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Gavriilidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-0438","authenticated-orcid":false,"given":"Michela","family":"Frenquelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-1199","authenticated-orcid":false,"given":"Alessandro","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Rovida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gerousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-6293","authenticated-orcid":false,"given":"Eleni","family":"Theodosiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-7123","authenticated-orcid":false,"given":"Styliani-Christina","family":"Fragkouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Vasileiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Sklaviadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Dafou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5342-4873","authenticated-orcid":false,"given":"George","family":"Mosialos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-6231","authenticated-orcid":false,"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0222-4273","authenticated-orcid":false,"given":"Fotis","family":"Psomopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-0528","authenticated-orcid":false,"given":"Thomas H.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-7342","authenticated-orcid":false,"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8759-8962","authenticated-orcid":false,"given":"Konstantinos","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"8555_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/embor.2009.55","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Reyes-Turcu F, Licchesi JDF, Odenwaelder P, Wilkinson KD, Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009;10:466\u201373.","journal-title":"EMBO Rep"},{"key":"8555_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/76006","volume":"25","author":"GR Bignell","year":"2000","unstructured":"Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000;25:160\u20135.","journal-title":"Nat Genet"},{"key":"8555_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/carcin\/bgt335","volume":"35","author":"RR Pannem","year":"2014","unstructured":"Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis. 2014;35:461\u20138.","journal-title":"Carcinogenesis"},{"key":"8555_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20082044","volume":"206","author":"R Massoumi","year":"2009","unstructured":"Massoumi R, Kuphal S, Hellerbrand C, Haas B, Wild P, Spruss T, et al. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med. 2009;206:221\u201332.","journal-title":"J Exp Med"},{"key":"8555_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14121","volume":"8","author":"YY Li","year":"2017","unstructured":"Li YY, Chung GTY, Lui VWY, To K-F, Ma BBY, Chow C, et al. Exome and genome sequencing of nasopharynx cancer identifies NF-\u03baB pathway activating mutations. Nat Commun. 2017;8:14121.","journal-title":"Nat Commun"},{"key":"8555_CR6","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI28746","volume":"116","author":"J Zhang","year":"2006","unstructured":"Zhang J, Stirling B, Temmerman ST, Ma CA, Fuss IJ, Derry JMJ, et al. Impaired regulation of NF-\u03baB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Investig. 2006;116:3042\u20139.","journal-title":"J Clin Investig"},{"key":"8555_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13402-016-0279-3","volume":"39","author":"DN Karatzas","year":"2016","unstructured":"Karatzas DN, Xanthopoulos K, Kotantaki P, Pseftogas A, Teliousis K, Hatzivassiliou EG, et al. Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report. Cell Oncol. 2016;39:287\u201393.","journal-title":"Cell Oncol"},{"key":"8555_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ccr.2012.04.026","volume":"21","author":"K Nikolaou","year":"2012","unstructured":"Nikolaou K, Tsagaratou A, Eftychi C, Kollias G, Mosialos G, Talianidis I. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer. Cancer Cell. 2012;21:738\u201350.","journal-title":"Cancer Cell"},{"key":"8555_CR9","doi-asserted-by":"publisher","unstructured":"Ling T, Yu F, Cao H. miR-182 controls cell growth in gastrointestinal stromal tumors by negatively regulating CYLD expression. Oncol Rep. 2018. https:\/\/doi.org\/10.3892\/or.2018.6765.","DOI":"10.3892\/or.2018.6765"},{"key":"8555_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0521-7","volume":"15","author":"D Xu","year":"2016","unstructured":"Xu D, Zhou P, Wang Y, Zhang L, Fu W, Ruan B, et al. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway. Mol Cancer. 2016;15:40.","journal-title":"Mol Cancer"},{"key":"8555_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cncr.30570","volume":"123","author":"M Hajek","year":"2017","unstructured":"Hajek M, Sewell A, Kaech S, Burtness B, Yarbrough WG, Issaeva N. TRAF3\/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma. Cancer. 2017;123:1778\u201390.","journal-title":"Cancer"},{"key":"8555_CR12","first-page":"8861","volume":"23","author":"K Jiang","year":"2019","unstructured":"Jiang K, Xie L-F, Xiao T-Z, Qiu M-Y, Wang W-L. MiR-181d inhibits cell proliferation and metastasis through PI3K\/AKT pathway in gastric cancer. Eur Rev Med Pharm Sci. 2019;23:8861\u20139.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"8555_CR13","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1182\/bloodadvances.2020003431","volume":"5","author":"Z Mo","year":"2021","unstructured":"Mo Z, Wood S, Namiranian S, Mizukoshi R, Weng S, Jang IS, et al. Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen. Blood Adv. 2021;5:2027\u201339.","journal-title":"Blood Adv"},{"key":"8555_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01891-2","volume":"21","author":"X Xu","year":"2021","unstructured":"Xu X, Wei T, Zhong W, Ang R, Lei Y, Zhang H, et al. Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma. Cancer Cell Int. 2021;21:195.","journal-title":"Cancer Cell Int"},{"key":"8555_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","volume":"12","author":"CM Annunziata","year":"2007","unstructured":"Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, et al. Frequent engagement of the classical and alternative NF-\u03baB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007;12:115\u201330.","journal-title":"Cancer Cell"},{"key":"8555_CR16","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1182\/blood-2007-02-075069","volume":"110","author":"MW Jenner","year":"2007","unstructured":"Jenner MW, Leone PE, Walker BA, Ross FM, Johnson DC, Gonzalez D, et al. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma. Blood. 2007;110:3291\u20133300.","journal-title":"Blood"},{"key":"8555_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","volume":"12","author":"JJ Keats","year":"2007","unstructured":"Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng W-J, et al. Promiscuous mutations activate the noncanonical NF-\u03baB pathway in multiple myeloma. Cancer Cell. 2007;12:131\u201344.","journal-title":"Cancer Cell"},{"key":"8555_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nature01811","volume":"424","author":"TR Brummelkamp","year":"2003","unstructured":"Brummelkamp TR, Nijman SMB, Dirac AMG, Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-\u03baB. Nature. 2003;424:797\u2013801.","journal-title":"Nature"},{"key":"8555_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature01802","volume":"424","author":"A Kovalenko","year":"2003","unstructured":"Kovalenko A, Chable-Bessia C, Cantarella G, Isra\u00ebl A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003;424:801\u20135.","journal-title":"Nature"},{"key":"8555_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature01803","volume":"424","author":"E Trompouki","year":"2003","unstructured":"Trompouki E, Hatzivassillou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003;424:793\u20136.","journal-title":"Nature"},{"key":"8555_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molcel.2010.01.035","volume":"37","author":"DVF Tauriello","year":"2010","unstructured":"Tauriello DVF, Haegebarth A, Kuper I, Edelmann MJ, Henraat M, Canninga-van Dijk MR, et al. Loss of the tumor suppressor CYLD enhances Wnt\/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell. 2010;37:607\u201319.","journal-title":"Mol Cell"},{"key":"8555_CR22","doi-asserted-by":"publisher","first-page":"12126","DOI":"10.18632\/oncotarget.2573","volume":"5","author":"N Rajan","year":"2014","unstructured":"Rajan N, Elliott RJR, Smith A, Sinclair N, Swift S, Lord CJ, et al. The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate notch signalling. Oncotarget. 2014;5:12126\u201340.","journal-title":"Oncotarget"},{"key":"8555_CR23","doi-asserted-by":"publisher","unstructured":"Yang Y, Zhou J. CYLD \u2013 a deubiquitylase that acts to fine-tune microtubule properties and functions. J Cell Sci 2016. https:\/\/doi.org\/10.1242\/jcs.183319.","DOI":"10.1242\/jcs.183319"},{"key":"8555_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/cdd.2009.43","volume":"17","author":"S-C Sun","year":"2010","unstructured":"Sun S-C. CYLD: a tumor suppressor deubiquitinase regulating NF-\u03baB activation and diverse biological processes. Cell Death Differ. 2010;17:25\u201334.","journal-title":"Cell Death Differ"},{"key":"8555_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1593\/neo.81424","volume":"11","author":"E Trompouki","year":"2009","unstructured":"Trompouki E, Tsagaratou A, Kosmidis SK, Doll\u00e1 P, Qian J, Kontoyiannis DL, et al. Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation. Neoplasia. 2009;11:469\u201376.","journal-title":"Neoplasia"},{"key":"8555_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms5585","volume":"5","author":"T Eguether","year":"2014","unstructured":"Eguether T, Ermolaeva MA, Zhao Y, Bonnet MC, Jain A, Pasparakis M, et al. The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells. Nat Commun. 2014;5:1\u201314.","journal-title":"Nat Commun"},{"key":"8555_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cell.2006.03.041","volume":"125","author":"R Massoumi","year":"2006","unstructured":"Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, F\u00e4ssler R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-\u03baB Signaling. Cell. 2006;125:665\u201377.","journal-title":"Cell"},{"key":"8555_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/ni1315","volume":"7","author":"W Reiley","year":"2006","unstructured":"Reiley W, Zhang M, Jin W, Losiewicz M, Donohue KB, Norbury CC, et al. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol. 2006;7:411\u20137.","journal-title":"Nat Immunol"},{"key":"8555_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.tibs.2010.02.007","volume":"35","author":"R Massoumi","year":"2010","unstructured":"Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci. 2010;35:392\u20139.","journal-title":"Trends Biochem Sci"},{"key":"8555_CR30","doi-asserted-by":"publisher","first-page":"15884","DOI":"10.1074\/jbc.M609952200","volume":"282","author":"W Jin","year":"2007","unstructured":"Jin W, Reiley WR, Lee AJ, Wright A, Wu X, Zhang M, et al. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B Cells *\u2666. J Biol Chem. 2007;282:15884\u201393.","journal-title":"J Biol Chem"},{"key":"8555_CR31","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1084\/jem.20070318","volume":"204","author":"N H\u00f6velmeyer","year":"2007","unstructured":"H\u00f6velmeyer N, Wunderlich FT, Massoumi R, Jakobsen CG, Song J, W\u00f6rns MA, et al. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med. 2007;204:2615\u201327.","journal-title":"J Exp Med"},{"key":"8555_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/leu.2017.168","volume":"32","author":"M Hahn","year":"2018","unstructured":"Hahn M, B\u00fcrckert JP, Luttenberger CA, Klebow S, Hess M, Al-Maarri M, et al. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-\u03baB signaling. Leukemia. 2018;32:72\u201382.","journal-title":"Leukemia"},{"key":"8555_CR33","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.1073\/pnas.0605944103","volume":"103","author":"E Hobeika","year":"2006","unstructured":"Hobeika E, Thiemann S, Storch B, Jumaa H, Nielsen PJ, Pelanda R, et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci USA. 2006;103:13789\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8555_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2010.01.007","volume":"354","author":"TM Holl","year":"2010","unstructured":"Holl TM, Haynes BF, Kelsoe G. Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods. 2010;354:53\u201367.","journal-title":"J Immunol Methods"},{"key":"8555_CR35","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u20133587.e29.","journal-title":"Cell"},{"key":"8555_CR36","doi-asserted-by":"crossref","unstructured":"Hao Y, Stuart T, Kowalski M, Choudhary S, Hoffman P, Hartman A et al. Dictionary learning for integrative, multimodal, and scalable single-cell analysis. bioRxiv 2022: 2022.02.24.481684.","DOI":"10.1101\/2022.02.24.481684"},{"key":"8555_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:1\u201315.","journal-title":"Genome Biol"},{"key":"8555_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20:163\u201372.","journal-title":"Nat Immunol"},{"key":"8555_CR39","doi-asserted-by":"crossref","unstructured":"Cannoodt R, Saelens W, Sichien D, Tavernier S, Janssens S, Guilliams M et al. SCORPIUS improves trajectory inference and identifies novel modules in dendritic cell development. bioRxiv 2016; 079509.","DOI":"10.1101\/079509"},{"key":"8555_CR40","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u2013D613.","journal-title":"Nucleic Acids Res"},{"key":"8555_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u2013D646.","journal-title":"Nucleic Acids Res"},{"key":"8555_CR42","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"8555_CR43","doi-asserted-by":"publisher","unstructured":"Yu J, Ding L, Shi H, Qian C, Burdyshaw C, Veloso J et al. scMINER: a mutual information-based framework for identifying hidden drivers from single-cell omics data. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2476875\/v1.","DOI":"10.21203\/rs.3.rs-2476875\/v1"},{"key":"8555_CR44","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gky458","volume":"46","author":"DJB Clarke","year":"2018","unstructured":"Clarke DJB, Kuleshov MV, Schilder BM, Torre D, Duffy ME, Keenan AB, et al. eXpression2Kinases (X2K) web: linking expression signatures to upstream cell signaling networks. Nucleic Acids Res. 2018;46:W171\u2013W179.","journal-title":"Nucleic Acids Res"},{"key":"8555_CR45","doi-asserted-by":"publisher","unstructured":"Mar\u00edn-Rubio JL, Raote I, Inns J, Dobson-Stone C, Rajan N. CYLD in health and disease. Dis Model Mech. 2023;16:050093. https:\/\/doi.org\/10.1242\/dmm.050093.","DOI":"10.1242\/dmm.050093"},{"key":"8555_CR46","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.4049\/jimmunol.181.3.1644","volume":"181","author":"XK Zhang","year":"2008","unstructured":"Zhang XK, Moussa O, LaRue A, Bradshaw S, Molano I, Spyropoulos DD, et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008;181:1644\u201354.","journal-title":"J Immunol"},{"key":"8555_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdermsci.2024.12.003","volume":"117","author":"K Awaji","year":"2025","unstructured":"Awaji K, Shibata S, Koyama A, Yamamoto T, Fukui Y, Toyama S, et al. Impact of Fli1 deletion on B cell populations: A focus on age-associated B cells and transcriptional dynamics. J Dermatol Sci. 2025;117:19\u201329.","journal-title":"J Dermatol Sci"},{"key":"8555_CR48","doi-asserted-by":"publisher","unstructured":"Clarke DJB, Evangelista JE, Xie Z, Marino GB, Maurya MR, Srinivasan S et al. Playbook workflow builder: interactive construction of bioinformatics workflows from a network of microservices. 2024. https:\/\/doi.org\/10.1101\/2024.06.08.598037.","DOI":"10.1101\/2024.06.08.598037"},{"key":"8555_CR49","doi-asserted-by":"publisher","first-page":"W338","DOI":"10.1093\/nar\/gkaf373","volume":"53","author":"GB Marino","year":"2025","unstructured":"Marino GB, Evangelista JE, Clarke DJB, Ma\u2019ayan A. L2S2: chemical perturbation and CRISPR KO LINCS L1000 signature search engine. Nucleic Acids Res. 2025;53:W338\u2013W350.","journal-title":"Nucleic Acids Res"},{"key":"8555_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","volume":"21","author":"J-H Park","year":"2004","unstructured":"Park J-H, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, et al. Suppression of IL7R\u03b1 transcription by IL-7 and other prosurvival cytokines. Immunity. 2004;21:289\u2013302.","journal-title":"Immunity"},{"key":"8555_CR51","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/ni.1667","volume":"9","author":"HS Dengler","year":"2008","unstructured":"Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol. 2008;9:1388\u201398.","journal-title":"Nat Immunol"},{"key":"8555_CR52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1084\/jem.20051038","volume":"202","author":"B Srivastava","year":"2005","unstructured":"Srivastava B, Quinn WJ, Hazard K, Erikson J, Allman D. Characterization of marginal zone B cell precursors. J Exp Med. 2005;202:1225\u201334.","journal-title":"J Exp Med"},{"key":"8555_CR53","doi-asserted-by":"publisher","unstructured":"Gavriilidis GI, Vasileiou V, Dimitsaki S, Karakatsoulis G, Giannakakis A, Pavlopoulos GA et al. APNet, an explainable sparse deep learning model to discover differentially active drivers of severe COVID-19. Bioinformatics 2025. https:\/\/doi.org\/10.1093\/bioinformatics\/btaf063.","DOI":"10.1093\/bioinformatics\/btaf063"},{"key":"8555_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112378","volume":"42","author":"E-M Cox","year":"2023","unstructured":"Cox E-M, El-Behi M, Ries S, Vogt JF, Kohlhaas V, Michna T, et al. AKT activity orchestrates marginal zone B cell development in mice and humans. Cell Rep. 2023;42:112378.","journal-title":"Cell Rep"},{"key":"8555_CR55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ni.2210","volume":"13","author":"K Ochiai","year":"2012","unstructured":"Ochiai K, Maienschein-Cline M, Mandal M, Triggs JR, Bertolino E, Sciammas R, et al. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol. 2012;13:300\u20137.","journal-title":"Nat Immunol"},{"key":"8555_CR56","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1084\/jem.180.5.1955","volume":"180","author":"JJ Peschon","year":"1994","unstructured":"Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 1994;180:1955\u201360.","journal-title":"J Exp Med"},{"key":"8555_CR57","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","volume":"181","author":"U Von Freeden-Jeffry","year":"1995","unstructured":"Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181:1519\u201326.","journal-title":"J Exp Med"},{"key":"8555_CR58","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.smim.2012.02.001","volume":"24","author":"SA Corfe","year":"2012","unstructured":"Corfe SA, Paige CJ. The many roles of IL-7 in B cell development; Mediator of survival, proliferation and differentiation. Semin Immunol. 2012;24:198\u2013208.","journal-title":"Semin Immunol"},{"key":"8555_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nri3570","volume":"14","author":"MR Clark","year":"2013","unstructured":"Clark MR, Mandal M, Ochiai K, Singh H. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol. 2013;14:69\u201380.","journal-title":"Nat Rev Immunol"},{"key":"8555_CR60","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood.2023019721","volume":"142","author":"FMP Kaiser","year":"2023","unstructured":"Kaiser FMP, Janowska I, Menafra R, de Gier M, Korzhenevich J, Pico-Knijnenburg I, et al. IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion. Blood. 2023;142:1113\u201330.","journal-title":"Blood"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08555-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:03:00Z","timestamp":1779213780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08555-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8555"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08555-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}